DRI Benzodiazepine Assay
K-Number: K173963 · 2018-02-21
Device Summary
Frequently Asked Questions
What is the DRI Benzodiazepine Assay?
DRI Benzodiazepine Assay is a medical device that received FDA 510(k) clearance on 2018-02-21. It is manufactured by Microgenics Corporation. The 510(k) number is K173963.
When was DRI Benzodiazepine Assay approved by the FDA?
DRI Benzodiazepine Assay received FDA 510(k) clearance on 2018-02-21, under approval number K173963.
What company makes DRI Benzodiazepine Assay?
DRI Benzodiazepine Assay is manufactured by Microgenics Corporation.
What is the FDA product code for DRI Benzodiazepine Assay?
The FDA product code for DRI Benzodiazepine Assay is JXM.
Other Devices by Microgenics Corporation
Related Devices (Code: JXM)
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.